-
15 provincial alliances collect and point to unevaluated varieties, and injections are the focus! What is the proportion of price factors?
Time of Update: 2022-11-14
On November 1 and 2, the official website of the State Food and Drug Administration successively released an announcement on the revision of drug instructions for a number of injection products, invo
-
The list of prohibited online sales of drugs is open for comments, and these drugs must not be sold online!
Time of Update: 2022-11-14
In order to further improve the relevant policies for the supervision of online drug sales and clarify the scope of online drug sales, the State Food and Drug Administration organized and drafted the "List of Prohibited Drug Online Sales (Draft for Comments)" for public solicitation of comments.
-
Announcement of the draft standard for disodium edetate pharmaceutical excipients (second time)
Time of Update: 2022-11-14
pdf National Pharmacopoeia Commission November 4, 2022Immediate feedback In order to ensure the scientificity, rationality and applicability of the standard, the proposed revised pharmaceutical excipient standard is hereby published for the second time to solicit opinions from all walks of life (see the annex for details).
-
Q3 performance inventory of Chinese medicine enterprises! Revenue reached 54.8 billion; The highest increase in net profit was 395%, Baiyun Mountain, Yunnan Baiyao, Pian Tsai, China Resources Sanjiu...
Time of Update: 2022-11-14
2022Q3 ranking of the top 10 net profit growth rate of traditional Chinese medicine enterprises year-on-year Data source: company financial report, flush money In the first three quarters of 2022, Jiaying Pharmaceutical achieved a net profit of 22.
-
In October, Merck and Novartis executives "flowed to each other", Hengrui and Qilu management changed, and Yongtai Biotech was suspended...
Time of Update: 2022-11-14
What has attracted much attention in the industry is the "mutual flow" of executives between MNCs. Following Yan Qiong's departure from Novartis to join Menarini, Tian Yu returned to his old club Novartis from Merck, and then Merck officially announced Brecht Vanneste to take over Tian Yu. In addition, many domestic and foreign pharmaceutical companies, including GSK, Hengrui Pharmaceutical, Qilu Pharmaceutical, etc.
-
The first time to break 5 billion, ointment pharmacies are selling well! Xi'an Janssen, China Resources Sanjiu... Leading
Time of Update: 2022-11-14
Top 10 Chinese urban pharmacy chemical ointment brands in 2021 (:100 million yuan)Source: Intranet China's urban physical pharmacy terminal competition pattern Note: Sales below 100 million yuan are indicated by * From the perspective of brands, there are 6 brands with sales of more than 100 million yuan, and Xi'an Janssen's miconazole nitrate cream, China Resources Sanjiu Pharmaceutical's compound dexamethasone acetate cream and Sino-American Tianjin SmithKline pharmaceutical mupirocin ointment ranked in the top three.
-
Orphan Drug Development: Shelter the World for Patients with Rare Diseases
Time of Update: 2022-11-14
Penicillin Chemical Structure 4 PLA2G6-related neurodegenerative diseases The FDA granted initial approval for RT001 (ethyl dideuterated linoleate for the treatment of PLA2G6-associated neurodegeneration (type 1 intrabrain iron deposition neurodegeneration, Figure 4) orphan drug in 2017.
-
The pharmaceutical sector may usher in performance opportunities, and subdivisions such as medical equipment and traditional Chinese medicine are optimistic
Time of Update: 2022-11-14
The third quarterly report of listed companies has disclosed that many pharmaceutical stocks have performed well, coupled with the marginal improvement of medical insurance policies, the industry believes that with the overall repair of market sentiment, it is expected to usher in performance opportunities, optimistic about medical equipment, traditional Chinese medicine, etc.
-
The State Food and Drug Administration approved the marketing of torudibin lafaxine hydrochloride sustained-release tablets
Time of Update: 2022-11-14
Source/ NMPA website Recently, the State Medical Products Administration approved the marketing of the Class 1 innovative drug Torudiven Lafaxine hydrochloride sustained-release tablets (trade name: Ruoxinlin) declared by Shandong Luye Pharmaceutical Co.
-
There are only ten clinical studies in the world, what are the ways out for new anti-cancer drugs targeting Nectin-4?
Time of Update: 2022-11-14
● Transmembrane domain ● Cytoplasmic domain, containing an AFADIN binding module Figure 2 Nectin-4 structure Source: Nature Drug Discovery Studies have shown that in the development of tumors, Nectin-4 is associated with promoting cancer cell proliferation and metastasis by activating the Rac small G protein in the WNT-β-catenin and PI3K-AKT signaling pathways.
-
Two new categories have been added to the list of prohibited online drugs, and there are still people "purchasing" hospital preparations?
Time of Update: 2022-11-14
The website of the State Food and Drug Administration recently released the "Prohibited List of Online Sales of Drugs (Draft for Comments)" (hereinafter referred to as the "Draft for Comments"), which intends to include preparations from medical institutions and granules of traditional Chinese medicine formulas in the prohibited list of online sales.
-
【Heavy】CDE released the "Technical Guidelines for the Design and Evaluation of Children's Drug Taste (Trial)"!
Time of Update: 2022-11-14
Notice of the Drug Review Center of the State Food and Drug Administration on the issuance of the Technical Guidelines for the Design and Evaluation of the Taste of Drugs for Children (Trial) (No. 37
-
The fine of 3 billion, nearly 10 years, why GlaxoSmithKline?
Time of Update: 2022-11-14
Foreign companies that violate the quality red line will also be severely punished According to the data of the National Medical Insurance Bureau, the average price reduction of selected drugs in the seven batches of centralized procurement has exceeded 50%, and the average price reduction of three batches of consumables has exceeded 80%, saving a cumulative cost of about 300 billion yuan.
-
What is CDE's consideration for the review of changes to drug clinical trial protocols? Here comes the guide!
Time of Update: 2022-11-14
In order to improve the quality of the applicant's preparation of clinical trial protocols, standardize the communication and exchange of clinical trial protocols and various registration application
-
In order to supplement their own strength, large pharmaceutical companies are accelerating "buying, buying and buying"
Time of Update: 2022-11-11
On Oct. 18, Eli Lilly said it had agreed to acquire precision genetic drug company Akou in a deal worth up to $610 million.
On Oct. 18, Eli Lilly said it had agreed to acquire precision genetic drug company Akou in a deal worth up to $610 million.
-
On the same day, a number of pharmaceutical companies announced that new drugs were approved for marketing!
Time of Update: 2022-11-11
Lukang Pharmaceutical On November 8, Lukang Pharmaceutical issued an announcement that essomeprazole sodium for injection received the "Drug Registration Certificate" issued by the State Food and Drug Administration and was approved for marketing.
-
Guangdong's 60 drugs began to cut prices at the end of this month, with an average price reduction of nearly half
Time of Update: 2022-11-11
The "Notice" clarifies that the seventh batch of state-organized centralized procurement of drugs, a total of 60 kinds of drugs were successfully purchased, with an average price reduction of 48%, involving 31 treatment categories, including hypertension, diabetes, anti-infection, digestive tract diseases and other common diseases, chronic diseases, as well as lung cancer, liver cancer, kidney cancer, bowel cancer and other major diseases.
-
At the end of the year, the organization focused on the pharmaceutical field, and nearly 4,000 surveys were conducted in a month
Time of Update: 2022-11-11
Data show that as of November 7, in the past month, the number of institutional surveys has exceeded 55,000, an increase of more than 36,000 times month-on-month; the number of listed companies survey
-
Pharmaceutical companies are accelerating the transformation of traditional production models to achieve cost reduction and efficiency increase!
Time of Update: 2022-11-11
The industry expects that with the development of science and technology, intelligent manufacturing will help pharmaceutical companies activate the "development code", through automated, intelligent, information-based production and testing equipment, to help pharmaceutical companies further improve production efficiency, reduce manual input, and achieve traceability, to ensure that traditional Chinese medicine products are more stable and controllable.
-
Institutional Research! The pharmaceutical stock has attracted the attention of more than 350 institutions
Time of Update: 2022-11-11
According to statistics from DataBao, in the past five trading days (October 31 to November 4), more than 360 listed companies in Shanghai and Shenzhen have been investigated by institutions, of which
